Invesco Biotechnology & Genome ETF Rating $89.59 -0.35 (-0.39%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.64Holdings in PBE have an aggregate rating of Moderate Buy based on 449 analyst ratings issued in the past year covering 25 companies (89.1% of the portfolio).PBE Aggregate Price Target$89.59High Prediction$89.59Average Prediction$89.59Low Prediction$89.59Holdings in PBE have an aggregate price target of $89.59 and a range of $89.59 to $89.59 covering 25 companies (89.1% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.98%VRTXVertex Pharmaceuticals$477.36+0.9%4.2749 of 5 stars2.88$559.61 17.2%25Positive News4.88%AMGNAmgen$376.04+1.2%4.0343 of 5 stars2.43$356.62 -5.2%30Positive News4.83%RPRXRoyalty Pharma$58.83-0.3%3.8649 of 5 stars3.00$56.57 -3.8%7News CoveragePositive NewsDividend Announcement4.77%BIIBBiogen$202.19+0.8%3.9219 of 5 stars2.53$220.57 9.1%32Upcoming EarningsAnalyst Forecast4.77%REGNRegeneron Pharmaceuticals$656.01+0.6%4.4539 of 5 stars2.70$787.88 20.1%27Trending NewsUpcoming EarningsAnalyst Forecast4.50%CDNACareDx$37.14-1.2%2.3505 of 5 stars2.00$33.67 -9.4%6Positive NewsUpcoming Earnings4.49%GILDGilead Sciences$129.31-1.2%4.9229 of 5 stars2.86$158.33 22.4%29Analyst Downgrade4.14%UTHRUnited Therapeutics$528.47-0.2%4.697 of 5 stars2.85$648.33 22.7%13News CoveragePositive NewsAnalyst Forecast4.05%ALNYAlnylam Pharmaceuticals$271.77+1.1%4.6062 of 5 stars2.85$452.13 66.4%26News CoverageUpcoming EarningsAnalyst Forecast3.67%TECHBio-Techne$71.60-0.2%2.6705 of 5 stars2.12$68.08 -4.9%17Positive News3.44%PTGXProtagonist Therapeutics$136.11+0.5%1.5304 of 5 stars2.94$123.00 -9.6%17News CoveragePositive NewsAnalyst Upgrade3.26%VCYTVeracyte$56.61-2.2%1.7988 of 5 stars2.60$55.88 -1.3%10Upcoming Earnings3.25%VCELVericel$45.05+0.0%3.4753 of 5 stars2.43$55.50 23.2%7Upcoming Earnings3.14%ILMNIllumina$194.09-1.4%2.344 of 5 stars2.37$156.88 -19.2%19Trending NewsUpcoming Earnings3.12%RGENRepligen$131.96-4.1%4.0657 of 5 stars2.88$165.36 25.3%17News CoverageUpcoming Earnings2.95%INCYIncyte$117.67+0.8%3.1786 of 5 stars2.36$111.10 -5.6%22News CoveragePositive NewsUpcoming EarningsAnalyst Forecast2.94%ACADACADIA Pharmaceuticals$24.84+0.0%4.6931 of 5 stars2.67$33.17 33.5%18Positive NewsAnalyst Forecast2.83%PTCTPTC Therapeutics$76.82-2.1%4.104 of 5 stars2.80$92.29 20.1%15News CoverageUpcoming EarningsShort Interest Decrease2.83%QGENQiagen$41.38-0.2%3.9593 of 5 stars2.36$43.34 4.8%14News CoveragePositive News2.76%HALOHalozyme Therapeutics$81.93+1.3%3.1511 of 5 stars2.54$81.60 -0.4%13News CoverageAnalyst Forecast2.75%BMRNBioMarin Pharmaceutical$59.33+0.8%4.5077 of 5 stars2.71$88.26 48.8%24News CoveragePositive News2.73%EXELExelixis$55.37-0.5%2.8766 of 5 stars2.40$49.00 -11.5%20News CoveragePositive NewsAnalyst Forecast2.68%NBIXNeurocrine Biosciences$175.77+0.9%4.5152 of 5 stars2.96$194.05 10.4%23News CoveragePositive NewsUpcoming EarningsAnalyst Forecast2.68%BCRXBioCryst Pharmaceuticals$9.34-0.4%3.165 of 5 stars2.67$20.80 122.7%12Short Interest Decrease2.61%COLLCollegium Pharmaceutical$35.20-1.1%3.0687 of 5 stars3.17$57.50 63.4%6News CoverageAnalyst Downgrade This page (NYSEARCA:PBE) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
